Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease

  • Magdaléna Neřoldová,
  • Elżbieta Ciara,
  • Janka Slatinská,
  • Soňa Fraňková,
  • Petra Lišková,
  • Radana Kotalová,
  • Janka Globinovská,
  • Markéta Šafaříková,
  • Lucie Pfeiferová,
  • Hana Zůnová,
  • Lenka Mrázová,
  • Viktor Stránecký,
  • Alena Vrbacká,
  • Ondřej Fabián,
  • Eva Sticová,
  • Daniela Skanderová,
  • Jan Šperl,
  • Marta Kalousová,
  • Tomáš Zima,
  • Milan Macek,
  • Joanna Pawlowska,
  • A. S. Knisely,
  • Stanislav Kmoch,
  •  [ ... ],
  • Milan Jirsa
  • [ view all ]
  • [ view less ]

There are errors in the S3 Table. In the S3B Table, the predicted translation of the heterozygous ABCB11 variant c.3589C>G found in the patient F39CE53 should shave been p.(Leu1197Val). In S3C Table, the variant found in the patient M11RO526 should be c.1798A>T and in patient F4RO528 should be c. 2545T>C. Please view the correct S3 Table below.

Supporting information

S3 Table. Variants detected by initial Sanger sequencing in 60 excluded patients.

https://doi.org/10.1371/journal.pone.0318705.s001

(DOCX)

Reference

  1. 1. Neřoldová M, Ciara E, Slatinská J, Fraňková S, Lišková P, Kotalová R, et al. (2023) Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease. PLOS ONE 18(7): e0288907. https://doi.org/10.1371/journal.pone.0288907

Citation: Neřoldová M, Ciara E, Slatinská J, Fraňková S, Lišková P, Kotalová R, et al. (2025) Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease. PLoS ONE 20(1): e0318705. https://doi.org/10.1371/journal.pone.0318705

Published: January 30, 2025

Copyright: © 2025 Neřoldová et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.